IL102473A - 2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor - Google Patents

2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor

Info

Publication number
IL102473A
IL102473A IL102473A IL10247392A IL102473A IL 102473 A IL102473 A IL 102473A IL 102473 A IL102473 A IL 102473A IL 10247392 A IL10247392 A IL 10247392A IL 102473 A IL102473 A IL 102473A
Authority
IL
Israel
Prior art keywords
carbons
alkyl
group
alkoxy
hydroxy
Prior art date
Application number
IL102473A
Other versions
IL102473A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL102473A0 publication Critical patent/IL102473A0/en
Publication of IL102473A publication Critical patent/IL102473A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compounds of the formula OH R1R(CH2)n MNO(CH2)m QR2R3 XY and the pharmaceutically-acceptable salts thereof; wherein R1, R2 and R3 are each selected from the group consisting of hydrogen, alkyl having 1 to 6 carbons, phenyl and phenyl substituted by hydroxy, alkyl having 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, amino, nitro or alkoxy having 1 to 4 carbons; or R1 and R2 when taken together form a methylene, ethylene, propylene or butylene group; R is OH, or when taken together with R1 form =O; m is 0 to 2; n is 1 or 2; X and Y are each selected from the group consisting of hydrogen, chloro, bromo, fluoro, trifluoromethyl, alkoxy having 1 to 4 carbons, alkyl having 1 to 4 carbons, hydroxy, amino, nitro and substituted phenoxy substituted by hydrogen, hydroxy, alkyl having 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, nitro, amino or alkoxy having 1 to 4 carbons; M and Q are each selected from the group consisting of hydrogen, hydroxy, amino, chloro, bromo, fluoro, trifluoromethyl, nitro, alkyl having 1 to 4 carbons, alkoxy having 1 to 4 carbons, N, N-dialkylamino having 1 to 4 carbons in each of said alkyls, N-alkylamino having 1 to 4 carbons, NHCOR4, NHCOOR5 and NHSO2R6; wherein R4 is selected from the group consisting of hydrogen, alkyl having 1 to 6 carbons, phenyl optionally substituted by hydroxy, chloro, bromo, fluoro, trifluoromethyl, amino, nitro, alkyl having 1 to 4 carbons or alkoxy having 1 to 4 carbons; and wherein R5 and R6 are each selected from the group consisting of alkyl having 1 to 4 carbons or alkoxy having 1 to 4 carbons; or M and Q when taken together form a divalent radical Z, wherein Z is selected from the group consisting of R7 R8 NNN OHOH OH NNN HH HNN ON HH2NN and wherein R7 and R8 are each selected from the group consisting of hydrogen and methyl. The compounds wherein R is hydroxy are for use in neuroprotective pharmaceutical compositions.
IL102473A 1991-07-17 1992-07-12 2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor IL102473A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17

Publications (2)

Publication Number Publication Date
IL102473A0 IL102473A0 (en) 1993-01-14
IL102473A true IL102473A (en) 1997-07-13

Family

ID=24940103

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102473A IL102473A (en) 1991-07-17 1992-07-12 2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor

Country Status (22)

Country Link
EP (1) EP0594729A1 (en)
JP (1) JP2571904B2 (en)
KR (1) KR0165003B1 (en)
CN (1) CN1043759C (en)
AU (1) AU655840B2 (en)
BR (1) BR9206272A (en)
CA (1) CA2113568A1 (en)
CZ (1) CZ284133B6 (en)
EG (1) EG20048A (en)
FI (2) FI981956L (en)
HU (1) HUT70528A (en)
IE (1) IE922311A1 (en)
IL (1) IL102473A (en)
MX (1) MX9204190A (en)
NO (1) NO180445C (en)
NZ (1) NZ243580A (en)
PL (1) PL169884B1 (en)
PT (1) PT100689B (en)
RU (1) RU2065859C1 (en)
TW (1) TW201732B (en)
WO (1) WO1993002052A1 (en)
ZA (1) ZA925306B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
DE69309297T2 (en) * 1992-10-30 1997-07-03 Pfizer NEUROPROTECTIVE 3,4-DIHYDRO-2 (1H) -CHINOLONE
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
US6978166B2 (en) 1994-10-07 2005-12-20 Saint Louis University System for use in displaying images of a body part
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
CA2220649C (en) * 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
AU3676100A (en) * 1999-04-09 2000-11-14 Mochida Pharmaceutical Co., Ltd. Remedies for neuropathic pain
TWI254043B (en) * 1999-06-08 2006-05-01 Hoffmann La Roche Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
JP2003512422A (en) 1999-10-29 2003-04-02 メルク シャープ エンド ドーム リミテッド Method of treating pain using a benzimidazole NMDA / NR2B antagonist
EA005974B1 (en) 2001-02-23 2005-08-25 Мерк Энд Ко., Инк. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
CA2443108A1 (en) 2001-04-03 2002-10-17 Merck & Co. Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
WO2004048326A1 (en) 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
MXPA06003748A (en) * 2003-10-08 2006-06-14 Pfizer Fused lactam compounds.
TWI409289B (en) 2010-09-02 2013-09-21 Taiwan Union Technology Corp Stable solution of the polymer prepared from n,o-heterocycles and its preparinging method and use
MX2022016183A (en) * 2020-06-23 2023-02-13 Biohaven Therapeutics Ltd Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (en) * 1983-05-19 1985-10-25 Synthelabo ENANTIOMERS OF ERYTHRO (BENZYL-4 PIPERIDINO) -2 (HYDROXY-4 OR BENZYLOXY-4 PHENYL) -1 PROPANOL, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2640266B2 (en) * 1988-07-12 1992-07-10 Synthelabo INDOLONES-2, QUINOLEINONES-2, BENZO (B) AZEPINONES-2 AND BENZIMIDAZOLONES-2 DERIVATIVES OF (HYDROXY-1 PIPERIDINYL-2 ALKYL), THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ES2098248T3 (en) * 1989-05-17 1997-05-01 Pfizer DERIVATIVES OF 2-PIPERIDINE-1-ALCANOLS AS ANTI-ISCHEMICAL AGENTS.
CA2080475C (en) * 1990-05-10 2001-04-17 Bertrand Leo Chenard Neuroprotective indolone and related derivatives

Also Published As

Publication number Publication date
NZ243580A (en) 1994-10-26
JPH06504293A (en) 1994-05-19
EG20048A (en) 1997-03-27
CZ400892A3 (en) 1994-03-16
HUT70528A (en) 1995-10-30
ZA925306B (en) 1994-01-17
CN1043759C (en) 1999-06-23
FI981956A7 (en) 1998-09-11
IL102473A0 (en) 1993-01-14
PT100689B (en) 1999-06-30
NO180445B (en) 1997-01-13
TW201732B (en) 1993-03-11
WO1993002052A1 (en) 1993-02-04
CN1068566A (en) 1993-02-03
NO940144D0 (en) 1994-01-14
NO180445C (en) 1997-04-23
AU655840B2 (en) 1995-01-12
HU9400136D0 (en) 1994-05-30
FI940192A0 (en) 1994-01-14
AU2322592A (en) 1993-02-23
CA2113568A1 (en) 1993-02-04
BR9206272A (en) 1995-04-11
FI940192A7 (en) 1994-01-14
PL169884B1 (en) 1996-09-30
NO940144L (en) 1994-01-14
JP2571904B2 (en) 1997-01-16
FI940192L (en) 1994-01-14
FI981956A0 (en) 1998-09-11
KR0165003B1 (en) 1999-01-15
RU2065859C1 (en) 1996-08-27
EP0594729A1 (en) 1994-05-04
MX9204190A (en) 1993-01-01
FI981956L (en) 1998-09-11
CZ284133B6 (en) 1998-08-12
PT100689A (en) 1993-10-29
IE922311A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
IL102473A (en) 2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor
NO952393D0 (en) Petroleum intermediate distillate mixture containing an additive which limits the deposition of paraffins
ES8103020A1 (en) Amino-ether oxides and use thereof in therapy
FI841181A0 (en) NYA N-PHENYL-N'- CYCLOALKYLALKANOYLPIPERAZINER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
NO990583L (en) Cyclic ether compounds as sodium channel modulators
IE811931L (en) Oxiranes.
EP0491659A3 (en) Novel piperidine compounds containing silane groups for use as stabilizers for organic materials
TR199802253T2 (en) Alkylaminobenzothiazole ve benzoxazole t�revleri
IE841659L (en) Allopurinol prodrugs
ES482002A1 (en) 5-Phenyl-pyrazole derivatives and their salts, processes for their preparation and medicines containing them.
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
SE8903226L (en) CHEMICAL SOCIETIES
AU4646596A (en) Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
ES482799A1 (en) Algicidal composition and method of preventing or controlling algae with said composition
SE8106441L (en) 2,6-C-DIMETHYLTYROSINE? 721-D-AMINO ACID
GB2183476B (en) Anthihypertensive combination product
EP0379085A3 (en) Phenyl alkyl amines and fungicides containing them
IE830469L (en) Fungicidal cyanopropenoates
SE7704246L (en) DISINFECTANT
ES2024332A6 (en) New sulfonamides as antifungal agents.
GB9419024D0 (en) Bicyclic carboxamides
ES8506605A1 (en) Process for the preparation of basic oxime ethers
ATE203533T1 (en) INDOLE DERIVATIVES AS PRODRUGS OF ß5-HT1-LIKES RECEPTOR AGONISTS
JPS564637A (en) Antistatic resin composition having excellent nonstickness
NO980842L (en) New Benzenesulfonylamine Compounds, Methods of Preparation thereof, and Pharmaceutical Compositions Containing Such

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees